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Abstract 18 
The lectin found in the tubers of the Winter Aconite (Eranthis hyemalis) plant is an N-acetyl-19 
D-galactosamine specific Type II Ribosome Inactivating Protein (RIP); Type II RIPs have 20 
shown anti-cancer properties, and hence have potential as therapeutic agents. Here we present 21 
a modified protocol for the extraction and purification of the E. hyemalis lectin (EHL) using 22 
affinity chromatography. De novo amino acid sequencing of EHL confirms its classification 23 
as a Type II Ribosome Inactivating protein. The biocidal properties of EHL have been 24 
investigated against the nematode Caenorhabditis elegans. Arrested first stage larvae treated 25 
with EHL have shown some direct mortality, with surviving larvae subsequently showing a 26 
range of phenotypes including food avoidance, reduced fecundity, developmental delay and 27 
constitutive dauer larvae formation. Both inappropriate dauer larvae development and failure 28 
to locate to bacterial food source are consistent with the disruption of chemosensory function 29 
and the ablation of amphid neurons. Further investigation indicates that mutations that disrupt 30 
normal amphid formation can block the EHL-induced dauer larvae formation. In 31 
combination, these phenotypes indicate that EHL is cytotoxic and suggest a cell specific 32 
activity against the amphid neurons of C. elegans.  33 
  34 
 35 
 36 
 37 
  38 
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Introduction 39 
 40 
Lectins are a class of carbohydrate binding proteins ubiquitously expressed in plants, animals, 41 
bacteria and viruses, characterised by their ability to agglutinate erythrocytes (Peumans & 42 
Van Damme, 1995), a property that enabled the development of the ABO system of blood 43 
typing.  The second characteristic common to all lectins is the ability to bind carbohydrates 44 
selectively based on the individual sugar specifity of the lectin.  This also results in lectins 45 
binding to the carbohydrate moieties of extracellular glycoconjugates specifically and 46 
reversibly without introducing conformational changes to the mono- or oligosaccharides to 47 
which they bind (Sharon & Lis, 2004).  Plant lectins are involved in a wide range of 48 
processes including carbohydrate transport, cell-cell signalling, cell surface binding and 49 
recognition, pathogenic defence and in potentially mediating symbiotic relationships (Sharon 50 
& Lis, 2004).  Plant lectins play a key role in defence, with many specifically binding to 51 
epithelial cells of herbivore and nematode guts (Schubert et al., 2012; Delatorre et al., 2007).  52 
Insecticidal, antifungal and antiviral qualities have also been widely described (e.g. Kumar et 53 
al., 1993; Rao et al., 1998; Peumans, Hao & Van Damme, 2001; Edwards & Gatehouse, 54 
2007).  For example, Balsamin, from Momordica balsamina, demonstrates potent anti-HIV 55 
activity (Kaur et al., 2013). 56 
 57 
In recent years the potential of lectins for use in cancer therapies has become a significant 58 
research focus due to their ability to preferentially bind to specific carbohydrates, and 59 
differentiate between glycosylation patterns.  Moreover, a number of plant derived lectins 60 
have been shown to have potent in vitro and in vivo anti-cancer effects (e.g. Voss et al., 2006; 61 
Otsuka et al., 2014) inducing autophagous and apoptotic pathways in tumour cells, and some 62 
are already used therapeutically.  For instance, the recombinant mistletoe lectin rViscumin 63 
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has been through phase 1 clinical trials and a number of other native mistletoe lectin 64 
preparations such as Lektinol and Iscador are prescribed widely throughout Europe as 65 
adjuvant therapies although their efficacy is not readily quantified (Horneber et al., 2008). 66 
 67 
Using a modified extraction protocol developed from previously published studies (Cammue, 68 
Peeters &Peumans 1985, Kumar et al. 1993, George et al. 2011). This paper focuses on the 69 
lectin found in the tubers of Winter Aconite, Eranthis hyemalis, (EHL).  To date, EHL is the 70 
sole lectin representative described from the Ranunculaceae and has been identified as a 71 
Type II Ribosome Inactivating Protein (RIP) (Kumar et al., 1993).  EHL preferentially binds 72 
N-acetyl-galactosamine, but also binds galactose, galacto-pyransosyl-D-glucose, and to a 73 
lesser degree D-ribose (Kumar et al., 1993).  Type II RIPs are classified as chimerolectins 74 
and cytotoxic N-glycosidases and consist of either one or two heterodimers linked by 75 
disulphide bonds.  The B chain subunit is a sugar specific lectin containing the highly 76 
conserved ricin B domain and will bind to extracellular glyconjugates. This mediates entry to 77 
the intracellular environment for the attached cytotoxic A chain by endocytosis (Virgilio et 78 
al., 2010).  The toxin is then subjected to retrograde transport via the Golgi complex; to the 79 
endoplasmic reticulum where the disulphide bonds are reduced and the A chain is free in the 80 
cytosol to refold into an enzymatically active form (Hartley & Lord, 2004).  The A chain acts 81 
as an inhibitor of eukaryotic protein synthesis by cleaving a single adenosine (A4234) in the 82 
28s rRNA subunit preventing Elongation Factor 2 from binding and resulting in immediate 83 
and absolute cessation of peptide elongation (Hartley & Lord, 2004). 84 
 85 
Type II RIPs are an area of increasing interest due to their antineoplastic properties, and their 86 
glycomic binding profile can be used to target specific glycans of biological molecules.  For 87 
instance, the GalNac specific RIP Ximenia americana (Riproximin) (Voss et al., 2006), 88 
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Sambucas sp (Ferreras et al., 2011) and ML1 from Viscum album (Tonevitsky et al., 1996) 89 
show higher binding affinity for tumour cells than for healthy cells.  This can be partly 90 
attributed to the expression of particular surface saccharide groups in the changing glycomics 91 
of malignant cells (Peumans, Hao & Van Damme, 2001; Bayer et al., 2012).  The use of 92 
lectins and Type II RIPs is also indicated in some studies for marking metastatic proliferation 93 
of tumour cells due to excessive glycosylation in metastatic cell lines (Zhou et al., 2015). 94 
 95 
Herein we present a modified extraction and purification protocol for EHL. Protein 96 
sequencing of EHL further supports the findings of earlier work that EHL is a Type II RIP. 97 
We also investigate the effect of EHL on the free living nematode Caenorhabditis elegans. C 98 
elegans is a well-established model organism for initial toxicological studies due to the 99 
conserved nature of its biological and biochemical processes including stress response and 100 
disease pathways (Boyd, Smith & Freedman, 2012).  Our research has revealed a range of 101 
phenotypes including direct mortality and a constitutive dauer formation phenotype that is 102 
consistent with neuronal ablation. 103 
 104 
Material and Methods 105 
Preparation of affinity chromatography column 106 
An Amersham chromatography column was packed at room temperature with a final bed 107 
volume of 8 ml of Fetuin-Agarose in solution with 0.5 M NaCl and immobilised on cross-108 
linked 4 % beaded agarose (Sigma-Aldrich Company ltd, UK).  Prior to use the column was 109 
equilibrated with 8 column volumes of Phosphate buffered solution (PBS). 110 
 111 
Extraction of EHL 112 
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60 g of E. hyemalis tubers supplied by Eurobulbs Ltd (UK) were prepared using a modified 113 
method from those described in previous studies (Cammue, Peeters & Peumans 1985, Kumar 114 
et al. 1993, George et al. 2011)  with adaptions as follows.  The tubers were finely sliced 115 
before being homogenised with 250 ml of ice cold PBS containing 5 mM thiourea and left to 116 
settle on ice for 30 minutes. The homogenate was removed and stored and the remaining 117 
slurry was mixed with a further 250 ml of PBS. The two fractions were then combined and 118 
stirred at 4°C for 4 hours. The homogenised mixture was then centrifuged (Sorvall RC6 plus 119 
HSC) at 20,000 g for 30 minutes. The supernatant was retained and frozen at -80°C overnight 120 
in order to induce aggregation of any remaining lipid content in sample. The sample was then 121 
defrosted and filtered through 3MM Whatman filter paper before undergoing a further 122 
centrifuge cycle of 20,000 g for 20 minutes. The clarified supernatant then underwent 123 
ammonium sulphate precipitation.  124 
 125 
Ammonium sulphate precipitation.  126 
Solid ammonium sulphate was added slowly to the crude extract initially to a saturation point 127 
of 40%, and after one hour of stirring at 4°C was centrifuged at 10,000g for 15 minutes.  The 128 
pellet was re-suspended in 15mls of PBS.  Ammonium sulphate was then added to the 129 
supernatant to a final saturation point of 80%, with a further hour of stirring at 4°C.  The 130 
resulting pellet was also re-suspended in PBS.  Agglutination activity was found to be 131 
retained in the 40% pellet and absent from the 80% pellet.  An SDS-PAGE gel confirmed the 132 
presence of target protein in the 40% fraction.  Samples were dialysed against PBS in 3 133 
buffer changes consisting of 200 x sample volume each including a final overnight exchange. 134 
 135 
Purification of EHL 136 
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The crude dialysed extract was applied to a Fetuin-agarose affinity chromatography column 137 
at a rate of 1 ml per minute using ÄKTA Express protein purification system (GE 138 
Healthcare), non-target proteins were then eluted with PBS until absorbance at λ280 was 139 
restored to base line value circa 40 mAU. The affinity matrix was then equilibrated with PBS 140 
and subsequently EHL was eluted with 40 mM 1,3 diaminopropanol (DAP) and peak 141 
fractions were collected in 0.5ml aliquots. The oligosaccharide structure of Fetuin has been 142 
well defined and shown to have Gal and GlcNAc branched residues present.  Fetuin has been 143 
purified using the lectin RCA I which has specificity for Galactose and N-144 
acetylgalactosamine (Green et al., 1988).  Its use, therefore as an affinity chromatography 145 
media for the lectin/type II RIP purification is based on this complementary interaction.  The 146 
eluant was neutralised with 2-Amino-2-hydroxymethyl-propane-1,3-diol hydrochloride (Tris-147 
HCl) at pH 7.0.  Peak fractions were applied to pre-equilibriated PD-10 desalting columns 148 
(GE Healthcare) and buffer exchanged into PBS. 149 
 150 
Analysis of EHL 151 
Purified EHL was tested for agglutination ability using defibrinated rabbit erythrocytes (TCS 152 
Biosciences), with 20 µl of post column eluant, or control, added to a 20 µl sample of 153 
erythrocytes in a welled microscope slide.  The purified EHL was also analysed by SDS-154 
PAGE, with both reduced and non-reduced samples electrophoresed on 12 % gels and 155 
subsequently stained with Coomassie Brilliant Blue.  Concentration was measured using a 156 
Qubit flourometric protein assay.  157 
 158 
Purified EHL was commercially sequenced.  In-gel tryptic digestion was performed after 159 
reduction with DTE and S-carbamidomethylation with iodoacetamide. Gel pieces were 160 
washed two times with 50% (v:v) aqueous acetonitrile containing 25 mM ammonium 161 
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bicarbonate, then once with acetonitrile and dried in a vacuum concentrator for 20 min.  162 
Sequencing-grade, modified porcine trypsin (Promega) was dissolved in the 50 mM acetic 163 
acid supplied by the manufacturer, then diluted 5-fold with 25 mM ammonium bicarbonate to 164 
give a final trypsin concentration of 0.02 µg/µL.  Gel pieces were rehydrated by adding 10 165 
µL of trypsin solution, and after 10 min enough 25 mM ammonium bicarbonate solution was 166 
added to cover the gel pieces.  Digests were incubated overnight at 37oC. 167 
 168 
A 1 µL aliquot of each peptide mixture was applied to a ground steel MALDI target plate, 169 
followed immediately by an equal volume of a freshly-prepared 5 mg/mL solution of 4-170 
hydroxy-α-cyano-cinnamic acid (Sigma) in 50% aqueous (v:v) acetonitrile containing 0.1% , 171 
trifluoroacetic acid (v:v).   172 
 173 
Positive-ion MALDI mass spectra were obtained using a Bruker ultraflex III in reflectron 174 
mode, equipped with a Nd:YAG smart beam laser.  MS spectra were acquired over a range of 175 
800-5000 m/z.  Final mass spectra were externally calibrated against an adjacent spot 176 
containing 6 peptides (des-Arg1-Bradykinin, 904.681; Angiotensin I, 1296.685; Glu1-177 
Fibrinopeptide B, 1750.677; ACTH (1-17 clip), 2093.086; ACTH (18-39 clip), 2465.198; 178 
ACTH (7-38 clip), 3657.929.). Monoisotopic masses were obtained using a SNAP averagine 179 
algorithm (C 4.9384, N 1.3577, O 1.4773, S 0.0417, H 7.7583) and a S/N threshold of 2.  180 
 181 
For each spot the ten strongest precursors, with a S/N greater than 30, were selected for 182 
MS/MS fragmentation. Fragmentation was performed in LIFT mode without the introduction 183 
of a collision gas. The default calibration was used for MS/MS spectra, which were baseline-184 
subtracted and smoothed (Savitsky-Golay, width 0.15 m/z, cycles 4); monoisotopic peak 185 
detection used a SNAP averagine algorithm (C 4.9384, N 1.3577, O 1.4773, S 0.0417, H 186 
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7.7583) with a minimum S/N of 6.  Bruker flexAnalysis software (version 3.3) was used to 187 
perform spectral processing and peak list generation. 188 
 189 
De novo sequencing of tandem mass spectra was performed by hand, with a-, b-, b0-, y-, y0- 190 
and y*-ions considered as possible fragment ions.  De novo derived peptides sequences were 191 
matched to homologous protein sequences using the on-line MS-BLAST service provided by 192 
Washington University.  The results of which were consistent with the in-house homology 193 
search results conducted on confidently assigned sequences using the University of Virginia 194 
UVa FASTA Server, the FASTS and SSearch algorithms were used for homology searching 195 
against the SwissProt (NCBI) and PDB databases. 196 
 197 
Activity against C. elegans 198 
Worms were obtained from the Caenorhabditis Genetics Center and maintained using 199 
standard methods (Stiernagle, 2006), on nematode growth media plates (NGM) using 200 
Escherichia coli OP50 strain food source. N2 was used for initial testing and as a control in 201 
other assays. To assess the effect of various mutations on EHL-induced dauer larvae 202 
formation, the following strains were used: CX2065, odr-1(n1936); CX2205 odr-3(n2150); 203 
PR671, tax-2(p671); PR672, che-1(p672); PR813, osm-5(p813); SP1205, dyf-1(mn335); and 204 
SP1709, dyf-10(e1383). In all experiments, treatments and genotypes were blind coded, the 205 
position of plates within experimental blocks was randomised, and contaminated plates 206 
excluded from all analysis. 207 
 208 
For all assays, arrested and synchronised C. elegans first stage larvae (L1s) were obtained by 209 
allowing eggs, isolated from gravid hermaphrodites by hypochlorite treatment (Stiernagle, 210 
2006), to hatch on NGM plates in the absence of food for 24 hours at 20°C. For experiment 1, 211 
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arrested N2 L1s were washed from plates, resuspended in M9 with a series of EHL 212 
concentrations from 3.92 to 0 mg/ml, incubated at 20°C for 6 hours, and 15 worms per 213 
treatment were picked for analysis.  For experiment 2, arrested N2 L1s treated as above 214 
except treatments were 2.94 mg/ml and 0 mg/ml EHL and a greater number of worms per 215 
treatment were analysed (n = 55 and n = 33 for the 2.94 and 0 mg/ml treatments, 216 
respectively).  After incubation, worms were washed 3 times in water. For the analysis of 217 
development and fecundity (experiments 1 and 2), worms were transferred in a small volume 218 
of liquid to NGM plates without food, then individually transferred from this plate to NGM 219 
plates with E. coli OP50 strain food source and maintained at 20°C.  Standard methods were 220 
then used to analyse the reproductive schedule and lifetime fecundity (Hodgkin & Doniach, 221 
1997).  These data were then used to assess the effect of EHL on reproduction as assessed by 222 
lifetime reproductive success (LRS), the total number of progeny produced (experiments 1 223 
and 2), and the intrinsic rate of increase (r) (experiment 2), calculated by iteration from Σe-224 
rxlxmx = 1, where lx represents the age specific survivorship to day x and mx represents the 225 
fecundity on day x (Vassilieva & Lynch, 1999). 226 
 227 
Based on phenotypes observed in the initial screen, the ability of EHL to induce constitutive 228 
dauer larvae formation (a dauer-constitutive, or Daf-c, phenotype) was investigated in greater 229 
detail.  Here, worms were treated with 0.98, 1.96 or 2.94 mg/ml EHL, as described above, 230 
except that after washing, worms were transferred en masse to plates with food.  After four 231 
days at 20°C plates were visually scored to assess the proportion of worms that had 232 
developed as dauer larvae (number of dauer larvae/total number of worms).  After counting, 233 
worms were washed from plates and incubated in 1 % SDS for one hour, a treatment that kills 234 
all C. elegans stages except dauer larvae (Cassada & Russell, 1975), worms were washed 235 
once in M9, transferred to fresh NGM plates with food and the number of dauer larvae again 236 
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counted.  These dauer larvae were then transferred individually to NGM plates with food at 237 
20°C and monitored for the next 14 days to determine if they were capable of resuming 238 
development.  To further analyse EHL-induced dauer larvae formation, N2 and mutant 239 
worms were treated, as described above, with 0, or 1.54 mg/ml EHL, washed, and transferred 240 
en masse to plates (n = 3 per combination of treatment and genotype) with food.  Plates were 241 
then incubated at 20°C for four days at which time the proportion of worms that had 242 
developed as dauer larvae was scored. 243 
 244 
Dauer larvae formation in PR672, che-1(p672), was further analysed both in standard dauer 245 
larvae formation assays and in assays of growing populations.  For assays of dauer larvae 246 
formation in response to defined amounts of pheromone, assays were performed as 247 
previously described (Golden & Riddle 1984; Green et al., 2014), with worms allowed to lay 248 
eggs on assay plates containing dauer pheromone extract and limited amounts of food, and 249 
progeny scored after two days at 25°C.  Dauer larvae formation in growing populations was 250 
assessed as previously described (Green et al., 2013), with populations initiated with single 251 
worms and a defined amount of food allowed to grow to food exhaustion, except that assays 252 
were performed at  25°C.  253 
 254 
Results 255 
Purification and characterisation of EHL 256 
Qubit fluorometric measurement showed a typical concentration of 2.5 mg/ml using our 257 
revised and improved purification strategy.  This shows an approximately 5 to 6-fold increase 258 
in recovery in comparison to the previously reported yield of 380 µg/ml in George et al. 259 
(2011). Non-reducing SDS-PAGE analysis produced characteristic reduced protein bands at 260 
circa 31 and 28 kDa as well as an unreduced band circa 50kDa (Fig. 1); these values are 261 
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consistent with those previously reported in the literature (Kumar et al., 1993).  An intense 262 
agglutination response of rabbit erythrocytes was exhibited and thus confirmed the presence 263 
of EHL (Fig. 2). 264 
 265 
De novo sequencing analysis.  266 
De novo sequence analysis of fragmentation spectra was carried out and suggested two 267 
confidently assigned peptide fragment sequences, with the following tags,  268 
QQWA[L/I]YSDST[L/I]R and NWNNNGNP[L/I]Q[L/I]WQCTQQQNQR (Fig. 3). Peptide 269 
fragment homology searches produced matches to various Type II Ribosome Inactivating 270 
Proteins (RIPS) all within ricin-b domain (carbohydrate binding) regions.  This result 271 
confirms the status of EHL as a Type II RIP, as has been reported in previously published 272 
sequence data (Kumar et al., 1993).  Sequence tags QQWA[L/I]YSDST[L/I]R and 273 
NWNNNGNP[L/I]Q[L/I]WQCTQQQNQR were matched to two regions in Nigrin-b (SNA-274 
V; Sambucas nigra agglutinin-V) UniProtKB P33183.2 correlating to residues 470-481 and 275 
325-345 respectively using the FASTS search facility against the SwissProt database.  Close 276 
homology to other Type II RIPS was also matched within the ricin b domain of Abrin-a 277 
(P11140) and Ricin (P02879).  PDB structures were searched using SSearch algorithm and 278 
also showed matches to SNA-II (3C9Z) (Sambucas nigra agglutinin II), Abrin-a (1ABRB) 279 
and Ricin (1RZOB) in the ricin b domain as well as ML1 from Viscum album (1QNKB).  280 
 281 
EHL affects survival, development and reproduction in C. elegans  282 
Acute treatment of arrested C. elegans L1s for 6 hours with EHL at different concentrations 283 
resulted in a subsequent range of developmental, fertility and survival defects  (Fig. 4), with 284 
all EHL concentrations reducing lifetime reproductive success (LRS) (Fig. 4A, pairwise, 285 
Bonferroni corrected, Mann–Whitney U tests against N2 showing reduced fecundity in all 286 
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EHL treatments).  Much of this decrease in fecundity is however a consequence of worms not 287 
reproducing in the EHL treatments (comparison of Fig. 4A and B), although LRS does still 288 
decrease over the range of EHL concentrations tested when only those worms that 289 
reproduced are considered (Fig. 4B, Pearson product-moment correlation of LRS against 290 
EHL concentration: including the 0 mg/ml group, r = -0.52, p < 0.001; excluding the 0 mg/ml 291 
group, r = -0.38, p = 0.013). EHL-treated worms that did reproduce showed a delay in 292 
development, with many treated worms starting reproduction a day or more after the control 293 
worms.  Of the worms that did not reproduce, some showed no movement from the point at 294 
which they were placed on the plate and no response to stimulus after 24 hours and therefore 295 
died as a consequence of the EHL treatment. Other EHL-treated worms were observed to 296 
remain as arrested L1s or to develop as dauer larvae, a non-feeding developmentally arrested 297 
stage.  Many of the non-reproducing worms were found not on a food source, and more than 298 
would be expected under these conditions were found to have climbed the sides of the plate; 299 
both behaviours are indicative of a disruption to chemosensory ability and an inability to 300 
detect the bacterial food.  301 
 302 
To investigate these reproductive effects and the survival in more detail, a larger number of 303 
worms were assayed (Fig. 5).  Here, EHL treatment resulted in immediate mortality of 41% 304 
of EHL treated individuals and again EHL-treated worms were observed to remain as L1s 305 
and to arrest as dauer larvae.  These results suggest that EHL treatment affects the sensory 306 
neurons.  Overall, EHL treatment reduced subsequent LRS (Fig. 5A, control vs all EHL 307 
treated worms, W = 2376.0, p < 0.001), with the subset of EHL treated worms that did 308 
reproduce producing a greatly reduced number of progeny (control vs reproducing EHL 309 
treated worms, W = 792.0, p < 0.001).  A similar pattern was observed in the analysis of the 310 
effects of EHL treatment on the estimated rate of increase (Fig. 5B, control vs all EHL treated 311 
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worms, W = 2376.0, p < 0.001; control vs reproducing EHL treated worms, W = 792.0, p < 312 
0.001).  313 
 314 
To further characterise the development of EHL-treated worms as dauer larvae, an additional 315 
set of arrested L1s were analysed.  As in the assay for reproductive effects (above), some of 316 
these EHL treated worms developed as dauer larvae (Fig. 6).  These worms were then SDS 317 
treated, with survival confirming that they were indeed dauer larvae.  Fifty of these dauer 318 
larvae were then transferred to plates with food and maintained at 20°C, with only one worm 319 
out of the fifty recovering and completing development as a reproductive adult after four 320 
days, and a second  recovering after a total of fourteen days.  Under these conditions dauer 321 
larvae normally recover rapidly and would be expected to have commenced reproduction 322 
approximately 2 days after transfer to food (Green & Harvey, 2012).   323 
 324 
Analysis of mutant strains indicates that the ability of EHL treatment to induce dauer larvae 325 
formation varied across the genotypes (Table 1). All genotypes were however observed to 326 
show a developmental delay in response to EHL treatment, with reproduction of most EHL-327 
treated worms not commencing until day 5 after treatment.  Analysis of dauer larvae 328 
formation in PR672, che-1(p672) showed that this mutation does not block dauer larvae 329 
formation in response to defined amounts of pheromone and that similar numbers of dauer 330 
larvae are formed in N2 and PR672 in growing populations (F1,33 = 0.05, p = 0.82).  331 
 332 
Discussion 333 
We have successfully isolated the type II RIP found in the tubers of the Winter Aconite, E. 334 
hyemalis, by modification of a previously published protocol (Cammue, Peeters & Peumans, 335 
1985; Kumar et al., 1993).  Analysis indicates EHL is a heterodimeric protein consisting of 336 
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two chains of molecular weights of approximately 28 and 31 kDa (Fig. 1). Protein sequencing 337 
confirms that EHL is a Type II RIP with the cytotoxic potential for depurination of 338 
eukaryotic ribosomes.  339 
 340 
EHL was used to study potential lectin-mediated toxicity against C. elegans.  The bioassays 341 
performed indicate that EHL has biocidal properties against C. elegans.  Four phenotypic 342 
effects were identified: reduced fecundity (Fig. 4 and 5), developmental delay, chemosensory 343 
disruption and constitutive dauer formation (Fig. 6 and Table 1).  C. elegans physiology is 344 
such that at the arrested L1 larval stage, the only cells which are not enclosed by a largely 345 
impermeable cuticle are the amphids and phasmids.  These are bilaterally symmetrical 346 
sensory organs that contain the sensory neurons: each amphid containing twelve neurons and 347 
each phasmid containing two (Ward et al., 1975).  Of the twelve amphid neurons, the ciliated 348 
nerve endings of eight are exposed to the external environment via the amphid pore (Ward et 349 
al., 1975).  These neurons control a range of phenotypes, including egg-laying and the 350 
decision to develop as a dauer larvae (Albert, Brown & Riddle, 1981). Laser ablation of the 351 
ASI, ADF and ASG cells is sufficient to result in constitutive dauer larvae development, with 352 
ablation of the ASJ cell resulting in an inability to recover from dauer arrest (Bargmann & 353 
Horvitz, 1991).  Our observations of inappropriate dauer larvae formation and the failure of 354 
most such dauer larvae to resume development indicate that EHL is interacting with these 355 
neurons and are consistent with EHL resulting in neuron death.  356 
 357 
In general, biocidal assays with lectins involve ingestion of the lectin by the target organism. 358 
For example, EHL had previously been tested against the coleopteran pest Diabrotica 359 
undecimpunctata howardii, resulting in a high mortality rate and an 80% reduction in body 360 
size of survivors; there was however no previous data on reproductive effects (Kumar et al., 361 
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1993). A study of the toxic effects of the CCL2 lectin from Coprnopsis cinerea (Ink Cap 362 
mushroom) on C. elegans reported a phenotype of severe developmental delay; the lectin was 363 
adsorbed in the epithelial cells of the intestine, potentially degrading the membrane and 364 
preventing growth (Schubert et al., 2012). The absence of a food source in our assay has 365 
therefore enabled the observation of entirely new lectin-mediated C. elegans phenotypes 366 
induced by EHL, including a Daf-c phenotype which has not been reported before.  367 
 368 
The cause of the developmental delay in EHL-treated worms is not clear. Possibilities would 369 
include damage to the pharynx and a subsequent reduction in pumping (feeding) ability, or, if 370 
some feeding is initiated, damage to the epithelial cells of the intestine as observed in 371 
response to the C. cinerea CCL2 lectin (Schubert et al., 2012). A further possibility is that 372 
differences in body size and development are also a consequence of damaged neurons (see 373 
Fujiwara, Sengupta & McIntire, 2002). 374 
 375 
Wild-type C. elegans take up dyes such as DiI and FITC into the amphid neurons AWB, 376 
ASH, ASJ, ASK, ADL and ASI (Hedgecock et al., 1985).  Given the likely mode of action of 377 
EHL, we reasoned that mutations that disrupt the normal formation of sensory amphids 378 
would block EHL-induced dauer larvae formation. Consistent with this, disruption of osm-5, 379 
dyf-1 and dyf-10, all mutations in which the amphid neurons cannot take up dyes, result in no 380 
EHL-induced dauer larvae formation (Table 1). In both odr-1 and odr-3 mutants, where dye 381 
filling is not affected and EHL would be expected to be able to access the neurons normally, 382 
there is no reduction in dauer larvae formation in response to EHL treatment (Table 1).  In 383 
contrast, dauer larvae formation is reduced in PR671, but some are still formed (Table 1), 384 
indicating that disruption of tax-2 only partially blocks the effect. TAX-2 forms, with TAX-4, 385 
a cyclic nucleotide-gated cation channel that is required for chemotaxis in response to AWC-386 
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sensed odorants (Coburn & Bargman, 1996).  Axon outgrowth defects have however been 387 
noted in tax-2 mutants, with c. 80% of tax-2(p671) animals observed to have abnormal ASJ 388 
axons (Coburn & Bargman, 1996).  It is not clear if the reduction in the EHL-induced dauer 389 
larvae formation observed in the tax-2 mutants is a consequence of the axon guidance defects 390 
or the channel disruption.   391 
  392 
That EHL-induced dauer larvae formation is also blocked in che-1 mutants further supports 393 
the hypothesis that EHL is disrupting neurons.   CHE-1 is a C2H2-type zinc-finger 394 
transcription factor that is required for the identity of ASE neurons (Uchida et al., 2003). 395 
Loss of CHE-1 expression eliminates the function of ASE neurons and che-1 mutations have 396 
previously been shown to suppress Daf-c phenotypes (Reiner et al., 2008).  No significant 397 
structural defects have been observed in che-1 mutants (Lewis & Hodgkin, 1977) and our 398 
results indicate that dauer larvae formation does not appear altered in either standard dauer 399 
larvae assays or in growing populations.  This thereby implies that the mutation is 400 
specifically blocking EHL-induced constitutive dauer larvae formation.  401 
It is well established that lectins bind to glyconjugates on cell surfaces and that toxicity in 402 
RIPs is due to lectin mediated entry to the cell; this mode of action is consistent with the 403 
results presented here. In the case of C. elegans the only cells exposed are the amphid 404 
neurons.  As a Type II RIP EHL can be subject to retrograde transport from the cell surface 405 
along the neuronal processes, at which point the ribosomes are inactivated, causing 406 
translation to cease (Wiley, Blessing & Reis, 1982).  As no post-embryonic somatic division 407 
occurs in mature individuals, and multiple chemoreceptors are expressed in a single neuron, 408 
ribosome inactivation of the neurons within the amphids would affect many functions derived 409 
from chemosensation (Sulston & Horvitz, 1977).  Toxicity variables can be attributed to 410 
differing carbohydrate specificities but there is also evidence of the role of individual cell 411 
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types in how they interact with lectins, indicating that any effects are characteristic of both 412 
variables (Battelli et al., 1997).  413 
 414 
In conclusion, successful extraction using affinity chromatography has enabled assays to be 415 
conducted for biocidal properties against C. elegans. The results obtained demonstrate a 416 
significant reduction in fecundity, development, growth and a high incidence of abnormal 417 
dauer development when arrested L1 larvae were treated in the absence of food.  The 418 
occurrence of dauer formation and a failure to recover in the presence of food supports the 419 
hypothesis that EHL is binding specifically to amphid neurons. Mutant screening has 420 
demonstrated that EHL can act as a neuronally specific cytotoxin, an effect which has 421 
previously been described with Ricin and other RIPs on mammalian sensory neurons (Wiley, 422 
Blessing & Reis, 1982; Tong et al., 2012).  Further studies will aim to determine if those 423 
individuals that remained as arrested L1s were doing so as a consequence of an inability to 424 
perceive the food or if an additional mechanism is at work. 425 
 426 
Our research shows that EHL has biocidal and potential cytotoxic activity. Moreover, EHL 427 
shows specificity for GalNac, an overexpressed sugar in the Tn (GalNac clustered) antigen 428 
which characterises cancer linked O-glycans (Ju, Otto & Cummings, 2011). Other GalNac 429 
Type II RIPs such as Mistletoe Lectin (ML1) and Riproximin have demonstrated promising 430 
therapeutic relevance as anticancer agents (Voss et al., 2006; Bayer et al., 2012; Adwan et 431 
al., 2014.  These factors suggest that EHL is a viable candidate for further study in respect of 432 
antineoplastic characteristics. 433 
 434 
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